PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Chemistry, Technical University of Munich, Garching, Germany.\', \'Institute of Virology, Technical University of Munich / Helmholtz Zentrum Munich, Munich, Germany.\', \'Formycon AG, Martinsried/Planegg, Germany.\', \'Institute of Virology, Technical University of Munich / Helmholtz Zentrum Munich, Munich, Germany; German Center for Infection Research, Munich Partner Site, Munich, Germany.\', \'Max von Pettenkofer Institute & Gene Center, Virology, LMU München, Munich, Germany; German Center for Infection Research, Munich Partner Site, Munich, Germany.\', \'Formycon AG, Martinsried/Planegg, Germany. Electronic address: carsten.brockmeyer@formycon.com.\', \'Institute of Virology, Technical University of Munich / Helmholtz Zentrum Munich, Munich, Germany; German Center for Infection Research, Munich Partner Site, Munich, Germany. Electronic address: protzer@tum.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0166-3542(21)00187-X10.1016/j.antiviral.2021.105197
?:doi
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 34774603
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34774603>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34774603>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all